Fundraising Fox
Carthera
Lyon, FR · Founded 2010 · 35 employees on LinkedIn · 5 known investors
Find your way into Carthera
Sign up to see every warm intro you have to Carthera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Carthera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Carthera develops SonoCloud®, an implantable ultrasound device that temporarily disrupts the blood-brain barrier to improve drug delivery to the brain for treatment of brain diseases including glioblastoma, brain metastases, and Alzheimer's Disease. The company's technology uses low-intensity pulsed ultrasound combined with microbubbles to increase therapeutic efficacy of existing and new therapies.
Founders & leadership
Carthera was founded in 2010 by Alexandre Carpentier.
Investors · 5
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Carthera do?
- Carthera develops SonoCloud®, an implantable ultrasound device that temporarily disrupts the blood-brain barrier to improve drug delivery to the brain for treatment of brain diseases including glioblastoma, brain metastases, and Alzheimer's Disease. The company's technology uses low-intensity pulsed ultrasound combined with microbubbles to increase therapeutic efficacy of existing and new therapies.
- Who founded Carthera?
- Carthera was founded by Alexandre Carpentier in 2010.
- Who are Carthera's investors?
- Carthera's investors include Supernova, Agoranov, Supernova Invest, Unorthodox Ventures, Panakes Partners.
- Where is Carthera headquartered?
- Carthera is headquartered in Lyon, FR.